Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

NCT00291057 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Lice Infestations

Interventions

DRUG: MALG

Sponsor

Sun Pharmaceutical Industries, Inc.